ArticleFrontiers in artificial intelligence2026
Harnessing the power of ANN for early detection and prediction of oral cancer.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Oral cancer affects millions of people worldwide, and early detection significantly improves treatment outcomes and survival rates. Conventional diagnostic approaches often face challenges related to subjectivity and delayed identification. In this context, artificial intelligence-based tools offer promising opportunities for rapid and reliable early screening. Methods: This study investigates the feasibility of using an Artificial Neural Network (ANN) to predict oral cancer risk based on optical refractive index (RI) features. RI data corresponding to reported INOK (normal oral cells) and YD-10B (oral cancer cells) cell lines were employed. To enhance model robustness and assess feasibility, the dataset was synthetically augmented. Multiple ANN architectures and hyperparameter configurations were systematically evaluated to identify the optimal network topology for classification. Results: The optimized ANN model demonstrated excellent performance in distinguishing between normal and oral cancer cell data. A precision score of 98.72% indicates that nearly all samples classified as cancerous were truly positive, minimizing false-positive predictions. Additionally, the model achieved a specificity of 99.00%, highlighting its strong capability to correctly identify non-cancerous cases. Discussion and conclusion: The high precision and specificity values underscore the effectiveness of ANN-based classification using optical refractive index features for oral cancer screening. By reducing false positives and preventing unnecessary anxiety among healthy individuals, the proposed approach offers significant clinical value. These findings demonstrate the potential of ANN-assisted optical analysis as a reliable and efficient tool for early oral cancer detection, paving the way for faster diagnosis and improved patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.